Everolimus enhances cellular cytotoxicity of lapatinib via the eukaryotic elongation factor-2 kinase pathway in nasopharyngeal carcinoma cells

BACKGROUND: Nasopharyngeal carcinoma (NPC) has a high relapse and metastatic rates; hence, development of new therapeutics is an immediate requirement. Lapatinib and everolimus have been demonstrated to be effective in the treatment of several carcinomas. This preclinical study aimed to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lin, Wang, Zhi-Hui, Han, Jun, Tang, Con, Chen, Nan, Lin, Zhong, Peng, Pei-Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067011/
https://www.ncbi.nlm.nih.gov/pubmed/27785067
http://dx.doi.org/10.2147/OTT.S115309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067011/
https://www.ncbi.nlm.nih.gov/pubmed/27785067
http://dx.doi.org/10.2147/OTT.S115309

Ejemplares similares